Jan 1, 2025, 09:17
Outcomes of BCMA CART in CNS Multiple Myeloma
Samer Al Hadidi, Assistant Professor at UAMS Myeloma Center, shared a post on X:
“Nice work Mahmoud Gaballa, Krina Patel initially presented ASCO24.
All patients had CNS responses though duration of response/PFS is sub-optimal.
CAR-Ts cross the BBB and in occasions in clinic were found to result in neurotoxicity though not reported in higher grades in this patient series.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 6, 2025, 11:11
Jan 6, 2025, 11:03
Jan 6, 2025, 10:45
Jan 6, 2025, 10:39
Jan 6, 2025, 10:31